Editor’s Commentary: Letters to the Editor, a New Publishing Partner, and Benefit-Risk Estimation J. Rick Turner Commentary 01 September 2011 Pages: 559 - 564
ABPM in Clinical Research Trials Lawrence Satin Letter to the Editor 01 September 2011 Pages: 568 - 568
Multiregional Clinical Trials: An Introduction from an Industry Perspective Bruce BinkowitzEkopimo Ibia Multiregional Clinical Trial 01 September 2011 Pages: 569 - 573
Points to Consider in Defining Region for a Multiregional Clinical Trial: Defining Region Work Stream in PhRMA MRCT Key Issue Team Yoko TanakaCarmen MakBruce Binkowitz Multiregional Clinical Trial 01 September 2011 Pages: 575 - 585
Impact of Different Regulatory Requirements for Trial Endpoints in Multiregional Clinical Trials Cynthia J. GirmanEkopimo IbiaBruce Binkowitz Multiregional Clinical Trial 01 September 2011 Pages: 587 - 594
Consistency of Treatment Effect across Regions in Multiregional Clinical Trials, Part 1: Design Considerations Joshua ChenHui QuanKimitoshi Ikeda Multiregional Clinical Trial 01 September 2011 Pages: 595 - 602
Consistency of Treatment Effect across Regions in Multiregional Clinical Trials, Part 2: Monitoring, Reporting, and Interpretation Paul GalloJoshua ChenKimitoshi Ikeda Multiregional Clinical Trial 01 September 2011 Pages: 603 - 608
Results of a Survey of PhRMA Member Companies on Practices Associated with Multiregional Clinical Trials Nick ScottBruce BinkowitzAndy Lee Multiregional Clinical Trial 01 September 2011 Pages: 609 - 617
Technical Requirements for Biopharmaceutics Classification System-Based Biowaiver in China Zhang NingPing Qi-neng Regulatory Affairs 01 September 2011 Pages: 619 - 625
Reporting of Adverse Drug Reactions by Community Pharmacists: A Qualitative Study in Quebec Benoît RouleauLouise LavoieChantal Collin Drug Information 01 September 2011 Pages: 627 - 639
Establishing a Complete Drug Information Triad: Academic, Industry, and Hospital Training Mina TadrousDaniel E. GharbawyKatie J. Suda Drug Information 01 September 2011 Pages: 641 - 644
Decision Making for a Companion Diagnostic in an Oncology Clinical Development Program Lee KaiserClaus BeckerBernard M. Fine Statistics 01 September 2011 Pages: 645 - 655
Japanese Guideline on Global Clinical Trials: Statistical Implications and Alternative Criteria for Assessing Consistency Kevin J. CarrollFlorence Le Maulf Statistics 01 September 2011 Pages: 657 - 667
Benefit/Risk Estimates in Clinical Trials Adil E. ShamooBilal M. Ayyub Clinical Trials 01 September 2011 Pages: 669 - 685
